The clinical study to correct multiple and large amount of administering to antipsychotic safely and effectively

The clinical study to correct multiple and large amount of administering to antipsychotic safely and effectively - The clinical study to correct multiple and large amount of administering to antipsychotic

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004511

Enrollment

400

Registered

2010-11-10

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Dosage losing of antipsychotics control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatient/ Outpatient who has schizophrenia. Taking antipsychotics 2 or more drugs and 500~1500mg/day(chrolpromazine). Taken informed consent.

Exclusion criteria

Exclusion criteria: Who have severe physical disease.

Design outcomes

Primary

Measure	Time frame
Manchester scale, EuroQOL	—

Countries

Japan

Contacts

Public ContactYoshio Yamanouchi

School of medicine, Fujita health university Dept of psychiatry

yamanouchi@ncnp.go.jp042-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026